Deferasirox 72603-0232-01
- Manufacturer
- Northstar Rx Llc
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- October 16, 2023
- Listing Expires
- December 31, 2026
- Application
- ANDA214474
Need to source Deferasirox? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Deferasirox | 180 mg/1 |
Drug Class
Iron Chelator [EPC]Cytochrome P450 1A2 Inhibitors [MoA]Cytochrome P450 2C8 Inhibitors [MoA]
Selected Package
72603-0232-01Selected30 TABLET, FILM COATED in 1 BOTTLE (72603-232-01)